Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival

被引：0
|
作者：
Hong-Lin Ke
Rong-Hu Ke
Bin Li
Xu-Hui Wang
Yong-Nan Wang
Xiao-Qiang Wang
机构：
[1] Shanghai Jiaotong University School of Medicine,Department of Emergency Medicine, Shanghai Sixth People’s Hospital
[2] Shanghai Jiaotong University School of Medicine,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital
[3] Shanghai Jiaotong University School of Medicine,Department of Neurosurgery, Xinhua Hospital
来源：
Acta Neurochirurgica | 2013年 / 155卷
关键词：
Meningioma; Laminin γ1; Extracellular matrix; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：165 / 171
页数：6
相关论文
共 50 条
  • [41] IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival
    Thon, Niklas
    Eigenbrod, Sabina
    Kreth, Simone
    Lutz, Juergen
    Tonn, Joerg-Christian
    Kretzschmar, Hans
    Peraud, Aurelia
    Kreth, Friedrich-Wilhelm
    CANCER, 2012, 118 (02) : 452 - 460
  • [42] Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study
    Lijun Zhang
    Chia-Wen Ko
    Shenghui Tang
    Rajeshwari Sridhara
    Therapeutic Innovation & Regulatory Science, 2013, 47 : 95 - 100
  • [43] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Beauchemin, C.
    Johnston, J. B.
    Lapierre, M.
    Aissa, F.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 350 - 350
  • [44] An Audit Strategy for Progression-Free Survival
    Dodd, Lori E.
    Korn, Edward L.
    Freidlin, Boris
    Gray, Robert
    Bhattacharya, Suman
    BIOMETRICS, 2011, 67 (03) : 1092 - 1099
  • [45] Bevacizumab 'prolongs progression-free survival'
    Saul, Helen
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (12) : 2136 - 2136
  • [46] Association Between Tumor Mutations and Meningioma Recurrence in Grade I/II Disease
    Dullea, Jonathan
    Rutland, John
    Gill, Corey M.
    Ranti, Daniel
    Arrighi-Allisan, Annie E.
    Kinoshita, Yayoi
    McBride, Russell
    Bederson, Joshua B.
    Donovan, Michael
    Sebra, Robert
    Fowkes, Mary
    Umphlett, Melissa
    Shrivastava, Raj K.
    NEUROSURGERY, 2022, 68 : 138 - 138
  • [47] A TARGETED GENE EXPRESSION BIOMARKER PREDICTS LOW GRADE MENINGIOMA RECURRENCE AND OVERALL SURVIVAL
    Nguyen, Minh
    Morshed, Ramin
    Youngblood, Mark
    Perlow, Haley
    Lucas, Calixto-Hope
    Patel, Akash
    Palmer, Joshua
    Mccortney, Kathleen
    Horbinski, Craig
    Magill, Stephen
    Chen, William
    Raleigh, David
    NEURO-ONCOLOGY, 2024, 26
  • [48] Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma
    Rabih Aboukais
    Marc Baroncini
    Fahed Zairi
    Nicolas Reyns
    Jean-Paul Lejeune
    Acta Neurochirurgica, 2013, 155 : 1385 - 1390
  • [49] Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma
    Aboukais, Rabih
    Baroncini, Marc
    Zairi, Fahed
    Reyns, Nicolas
    Lejeune, Jean-Paul
    ACTA NEUROCHIRURGICA, 2013, 155 (08) : 1385 - 1390
  • [50] Stem Cell Markers in Neoplasms and their Relationship with Progression-free and Overall Survival in Patients with Recurrence
    Eguiluz-Melendez, Aldo
    Rubio-Osornio, Carmen
    Rosiles-Abonce, Artemio
    Mendoza, Cesar
    Ramirez-Ordas, Miryam
    Rivera-Canas, Romina
    Tena-Suck, Martha
    Gomez-Amador, Juan Luis
    Moreno-Jimenez, Sergio
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024,
12345